About Christopher Ackerley
Christopher Ackerley is a director at Solius Labs.
Christopher Ackerley first appears on SEC filings in 2018.
Experience
This experience comes from Christopher Ackerley's profile and from SEC filings. For roles taken from filings, the years are when the filings name Christopher Ackerley in the role, so the role may have started earlier or lasted longer.
AG
Ackerley Sports Group Current
Partner
2023 – Present
EE
ESH Acquisition Corp. (NASDAQ: ESHA) Current
Director
2023 – Present
LU
Leeds United Current
Investor
2023 – Present
AT
American Tower Current
Venue Consulting Group
2022 – Present
TG
Taubman Center for State & Local Government Current
Advisory Board Member
2021 – Present
SR
Seattle Seawolves Rugby Current
Investor
2021 – Present
CG
Chihuly Garden and Glass Current
Board Director/Chair - Governance Committee
2016 – Present
SN
Space Needle Current
Board Director/Chair - Governance Committee
2016 – Present
Solius Labs, Inc. Current
Director
2015 – Present · Bainbridge Island, WA
Solius sells a light therapy device that stimulates vitamin D production in adults.
WB
Washington Trust Bank Current
Board Director/Chair - Trust Committee
2012 – Present
FS
Four Seasons Hotel Seattle Current
Board Member
2011 – Present
AL
Ackerley Partners LLC Current
Partner
2002 – Present
CF
Coachella Valley Firebirds
Investor
2022 – 2026
SK
Seattle Kraken
Executive Committee/Investor
2018 – 2026
LI
Limeade
Board Director/Chair - Audit & Risk Committee
2007 – 2022
CI
Concure Oncology / Breast Microseed Inc.
Board Director
2014 – 2021
AI
Ackerley Group Inc
President
1999 – 2002
Key Colleagues at Startups
The people Christopher Ackerley works with at each company, as listed on that company's latest Form D.
Solius Labs, Inc. · Form D, May 14, 2026
RW
Rick White
Director
BP
Brett Parent
Director
SH
Scott Hirsch
Director
RW
Robert Wise
Chief Financial Officer
DG
David Good
Chief Special Projects Officer
Chris Kiple
Chief Executive Officer and director